AI Multi-Omics Analytics Market Size, Revenue, Trend Report 2026 to 2035
Segmentations AI Multi-Omics Analytics Market:
AI Multi-Omics Analytics Market by Offering -
- Software Platforms
- Analytics Services
AI Multi-Omics Analytics Market by Omics Data Type-
- Genomics
- Transcriptomics
- Proteomics
- Metabolomics
- Epigenomics
- Others
AI Multi-Omics Analytics Market by Application -
- Drug Discovery and Development
- Biomarker Discovery
- Clinical Diagnostics and Precision Medicine
- Others
AI Multi-Omics Analytics Market by AI Technology -
- Machine Learning
- Deep Learning
- Others
AI Multi-Omics Analytics Market by End User -
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospitals and Clinical Laboratories
- Contract Research Organizations (CROs)
- Others
AI Multi-Omics Analytics Market by Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East and Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI Multi-Omics Analytics Market Snapshot
Chapter 4. Global AI Multi-Omics Analytics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Restraints & Challenges
4.4. Market Opportunities
4.5. Market Trends
4.6. AI Multi-Omics Analytics Technology Landscape Analysis
4.7. Software Platforms Analysis
4.8. Analytics Services Analysis
4.9. Genomics Data Analysis
4.10. Transcriptomics Data Analysis
4.11. Proteomics Data Analysis
4.12. Metabolomics Data Analysis
4.13. Epigenomics Data Analysis
4.14. Machine Learning Analysis
4.15. Deep Learning Analysis
4.16. Drug Discovery and Development Analysis
4.17. Biomarker Discovery Analysis
4.18. Clinical Diagnostics and Precision Medicine Analysis
4.19. AI Multi-Omics Analytics Value Chain Analysis
4.20. Porter’s Five Forces Analysis
4.21. Competitive Landscape & Market Share Analysis
4.22. Market Attractiveness Analysis
Chapter 5. AI Multi-Omics Analytics Market Segmentation: By Offering
5.1. Market Share, 2025 & 2035
5.2. Market Size (US$ Mn), 2022–2035
5.2.1. Software Platforms
5.2.2. Analytics Services
Chapter 6. AI Multi-Omics Analytics Market Segmentation: By Omics Data Type
6.1. Market Share, 2025 & 2035
6.2. Market Size (US$ Mn), 2022–2035
6.2.1. Genomics
6.2.2. Transcriptomics
6.2.3. Proteomics
6.2.4. Metabolomics
6.2.5. Epigenomics
6.2.6. Others
Chapter 7. AI Multi-Omics Analytics Market Segmentation: By AI Technology
7.1. Market Share, 2025 & 2035
7.2. Market Size (US$ Mn), 2022–2035
7.2.1. Machine Learning
7.2.2. Deep Learning
7.2.3. Others
Chapter 8. AI Multi-Omics Analytics Market Segmentation: By Application
8.1. Market Share, 2025 & 2035
8.2. Market Size (US$ Mn), 2022–2035
8.2.1. Drug Discovery and Development
8.2.2. Biomarker Discovery
8.2.3. Clinical Diagnostics and Precision Medicine
8.2.4. Others
Chapter 9. AI Multi-Omics Analytics Market Segmentation: By End User
9.1. Market Share, 2025 & 2035
9.2. Market Size (US$ Mn), 2022–2035
9.2.1. Pharmaceutical and Biotechnology Companies
9.2.2. Academic and Research Institutes
9.2.3. Hospitals and Clinical Laboratories
9.2.4. Contract Research Organizations (CROs)
9.2.5. Others
Chapter 10. Regional AI Multi-Omics Analytics Market Estimates & Trend Analysis
10.1. Global Market Regional Snapshot, 2025 & 2035
10.2. North America
10.2.1. Market Revenue by Country (U.S., Canada, Mexico), 2022–2035
10.2.2. North America AI Multi-Omics Analytics Market Revenue by Offering, 2022–2035
10.2.3. North America AI Multi-Omics Analytics Market Revenue by Omics Data Type, 2022–2035
10.2.4. North America AI Multi-Omics Analytics Market Revenue by AI Technology, 2022–2035
10.2.5. North America AI Multi-Omics Analytics Market Revenue by Application, 2022–2035
10.2.6. North America AI Multi-Omics Analytics Market Revenue by End User, 2022–2035
10.3. Europe
10.3.1. Market Revenue by Country (Germany, U.K., France, Italy, Spain, Rest of Europe), 2022–2035
10.3.2. Europe AI Multi-Omics Analytics Market Revenue by Offering, 2022–2035
10.3.3. Europe AI Multi-Omics Analytics Market Revenue by Omics Data Type, 2022–2035
10.3.4. Europe AI Multi-Omics Analytics Market Revenue by AI Technology, 2022–2035
10.3.5. Europe AI Multi-Omics Analytics Market Revenue by Application, 2022–2035
10.3.6. Europe AI Multi-Omics Analytics Market Revenue by End User, 2022–2035
10.4. Asia Pacific
10.4.1. Market Revenue by Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific), 2022–2035
10.4.2. Asia Pacific AI Multi-Omics Analytics Market Revenue by Offering, 2022–2035
10.4.3. Asia Pacific AI Multi-Omics Analytics Market Revenue by Omics Data Type, 2022–2035
10.4.4. Asia Pacific AI Multi-Omics Analytics Market Revenue by AI Technology, 2022–2035
10.4.5. Asia Pacific AI Multi-Omics Analytics Market Revenue by Application, 2022–2035
10.4.6. Asia Pacific AI Multi-Omics Analytics Market Revenue by End User, 2022–2035
10.5. Latin America
10.5.1. Market Revenue by Country (Brazil, Mexico, Argentina, Rest of Latin America), 2022–2035
10.5.2. Latin America AI Multi-Omics Analytics Market Revenue by Offering, 2022–2035
10.5.3. Latin America AI Multi-Omics Analytics Market Revenue by Omics Data Type, 2022–2035
10.5.4. Latin America AI Multi-Omics Analytics Market Revenue by AI Technology, 2022–2035
10.5.5. Latin America AI Multi-Omics Analytics Market Revenue by Application, 2022–2035
10.5.6. Latin America AI Multi-Omics Analytics Market Revenue by End User, 2022–2035
10.6. Middle East & Africa
10.6.1. Market Revenue by Country (GCC Countries, South Africa, Rest of Middle East & Africa), 2022–2035
10.6.2. Middle East & Africa AI Multi-Omics Analytics Market Revenue by Offering, 2022–2035
10.6.3. Middle East & Africa AI Multi-Omics Analytics Market Revenue by Omics Data Type, 2022–2035
10.6.4. Middle East & Africa AI Multi-Omics Analytics Market Revenue by AI Technology, 2022–2035
10.6.5. Middle East & Africa AI Multi-Omics Analytics Market Revenue by Application, 2022–2035
10.6.6. Middle East & Africa AI Multi-Omics Analytics Market Revenue by End User, 2022–2035
Chapter 11. Competitive Landscape
11.1. Key Strategic Developments (Partnerships, Acquisitions, Product Launches, Collaborations, and Technology Investments)
11.2. Market Share Analysis, 2026
11.3. Competitive Benchmarking
11.4. Company Profiles
11.4.1. Illumina, Inc.
11.4.2. Thermo Fisher Scientific Inc.
11.4.3. QIAGEN N.V.
11.4.4. Agilent Technologies, Inc.
11.4.5. SOPHiA GENETICS SA
11.4.6. DNAnexus, Inc.
11.4.7. Tempus AI, Inc.
11.4.8. Owkin, Inc.
11.4.9. Recursion Pharmaceuticals, Inc.
11.4.10. Athos Therapeutics, Inc.
11.4.11. Other Prominent Players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
AI Multi-Omics Analytics Market Size is valued at USD 0.99 Bn in 2025 and is predicted to reach USD 11.67 Bn by the year 2035
The AI Multi-Omics Analytics Market is expected to grow at a 28.2% CAGR during the forecast period for 2026 to 2035
Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., SOPHiA GENETICS SA, DNAnexus, Inc., Tempus AI, Inc., Owkin, Inc., Recursion Pharmaceuticals, Inc., Athos Therapeutics, Inc. and Others.
AI Multi-Omics Analytics Market is segmented into Offering, Omics Data Type, AI Technology, Application, End User and Other.
North America region is leading the AI Multi-Omics Analytics Market.